This inventor holds 1 USPTO granted patent. Top assignee: Karolinska Innovations Ab. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Antonio Barragan: Innovator in Malaria Research
Introduction
Antonio Barragan is a notable inventor based in Huddinge, Sweden. He has made significant contributions to the field of malaria research, particularly through his innovative work on malaria polypeptides. His research aims to enhance the understanding and treatment of malaria, a disease that continues to affect millions worldwide.
Latest Patents
Antonio Barragan holds a patent for "Malaria polypeptides." This invention relates to carbohydrates that can act as receptors for malaria antigens found on the surfaces of malaria-infected erythrocytes. The receptors described in his patent comprise negatively charged glycosaminoglycan-like moieties, preferably sulphated. Additionally, the invention includes novel malaria polypeptides that can function as ligands in relation to these receptors. The patent also encompasses the use of these polypeptides as medicaments, pharmaceutical compositions containing them, and antibodies directed against the new ligands.
Career Highlights
Antonio Barragan is associated with Karolinska Innovations AB, where he continues to advance his research in malaria. His work is pivotal in developing new therapeutic strategies to combat malaria, which remains a global health challenge.
Collaborations
Antonio has collaborated with esteemed colleagues such as Chen Qijun and Mats Wahlgren. These collaborations have further enriched his research and contributed to the advancement of malaria studies.
Conclusion
Antonio Barragan's innovative work in malaria research exemplifies the importance of scientific inquiry in addressing global health issues. His contributions through patents and collaborations highlight the potential for new treatments in the fight against malaria.